Healthcare -
Biotechnology - NASDAQ - US
$ 4.01
-5.87 %
$ 48.5 M
Market Cap
-1.9
P/E
NRXP - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NRXP - NRx Pharmaceuticals, Inc.
6.2 M
LAST VALUE
-68.74%
2 YEAR CAGR
55.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR